{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/drug-approvals/recent","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://api.fda.gov/drug/drugsfda.json","generated_at":"2026-11-16T04:55:08.479Z"},"count":50,"items":[{"application_number":"NDA221291","sponsor_name":"BAYER HEALTHCARE","application_type":"NDA","primary_brand_name":null,"generic_name":null,"approval_date":"2026-11-09","application_type_full":"New Drug Application","canonical_url":"https://api.morvs.ai/drug-approval/NDA221291"},{"application_number":"NDA219457","sponsor_name":"FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP LLC","application_type":"NDA","primary_brand_name":"MULTIBIC","generic_name":"Multibic","approval_date":"2026-11-09","application_type_full":"New Drug Application","canonical_url":"https://api.morvs.ai/drug-approval/NDA219457"},{"application_number":"NDA221093","sponsor_name":"AVYXA HOLDINGS","application_type":"NDA","primary_brand_name":"OXDERYS","generic_name":"Doxorubicin Hydrochloride","approval_date":"2026-11-09","application_type_full":"New Drug Application","canonical_url":"https://api.morvs.ai/drug-approval/NDA221093"},{"application_number":"ANDA217589","sponsor_name":"MICRO LABS","application_type":"ANDA","primary_brand_name":"BRIMONIDINE TARTRATE AND TIMOLOL MALEATE","generic_name":"Brimonidine Tartrate","approval_date":"2026-11-06","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA217589"},{"application_number":"ANDA220832","sponsor_name":"APPCO","application_type":"ANDA","primary_brand_name":"BRIVARACETAM","generic_name":"Brivaracetam","approval_date":"2026-11-06","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220832"},{"application_number":"ANDA220619","sponsor_name":"YICHANG HUMANWELL","application_type":"ANDA","primary_brand_name":"VENLAFAXINE HYDROCHLORIDE","generic_name":"Venlafaxine Hydrochloride","approval_date":"2026-11-06","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220619"},{"application_number":"ANDA218617","sponsor_name":"AUROBINDO PHARMA LTD","application_type":"ANDA","primary_brand_name":"TAFAMIDIS MEGLUMINE","generic_name":"Tafamidis Meglumine","approval_date":"2026-11-06","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA218617"},{"application_number":"ANDA221019","sponsor_name":"CHANGZHOU PHARM","application_type":"ANDA","primary_brand_name":"ELTROMBOPAG OLAMINE","generic_name":"Eltrombopag Olamine","approval_date":"2026-11-05","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA221019"},{"application_number":"ANDA219639","sponsor_name":"CMP DEV LLC","application_type":"ANDA","primary_brand_name":"AMITRIPTYLINE HYDROCHLORIDE","generic_name":"Amitriptyline Hydrochloride","approval_date":"2026-11-05","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA219639"},{"application_number":"NDA215783","sponsor_name":"INFORLIFE","application_type":"NDA","primary_brand_name":"PHENYLEPHRINE HYDROCHLORIDE IN SODIUM CHLORIDE","generic_name":"Phenylephrine Hydrochloride In Sodium Chloride","approval_date":"2026-11-05","application_type_full":"New Drug Application","canonical_url":"https://api.morvs.ai/drug-approval/NDA215783"},{"application_number":"ANDA209917","sponsor_name":"TEVA PHARMS USA INC","application_type":"ANDA","primary_brand_name":"FLUTICASONE PROPIONATE","generic_name":"Fluticasone Propionate","approval_date":"2026-11-03","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA209917"},{"application_number":"ANDA220300","sponsor_name":"ESJAY PHARMA","application_type":"ANDA","primary_brand_name":"HYDROXYUREA","generic_name":"Hydroxyurea","approval_date":"2026-11-03","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220300"},{"application_number":"ANDA203421","sponsor_name":"BAXTER HLTHCARE CORP","application_type":"ANDA","primary_brand_name":"PROPOFOL","generic_name":"Propofol","approval_date":"2026-11-03","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA203421"},{"application_number":"ANDA210890","sponsor_name":"AMNEAL PHARMS","application_type":"ANDA","primary_brand_name":"CYCLOPHOSPHAMIDE","generic_name":"Cyclophosphamide","approval_date":"2026-11-02","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA210890"},{"application_number":"ANDA219662","sponsor_name":"GLAND","application_type":"ANDA","primary_brand_name":"METHYLPREDNISOLONE ACETATE","generic_name":"Methylprednisolone Acetate","approval_date":"2026-11-02","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA219662"},{"application_number":"ANDA218447","sponsor_name":"ADAPTIS","application_type":"ANDA","primary_brand_name":"CARBAMAZEPINE","generic_name":"Carbamazepine","approval_date":"2026-11-02","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA218447"},{"application_number":"ANDA208522","sponsor_name":"ACTAVIS LABS FL","application_type":"ANDA","primary_brand_name":"CARBIDOPA AND LEVODOPA","generic_name":"Carbidopa","approval_date":"2026-11-02","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA208522"},{"application_number":"ANDA216996","sponsor_name":"NANJING KING FRIEND","application_type":"ANDA","primary_brand_name":"CALCITONIN-SALMON","generic_name":"Calcitonin Salmon","approval_date":"2026-10-29","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA216996"},{"application_number":"NDA220748","sponsor_name":"AVYXA HOLDINGS, LLC.","application_type":"NDA","primary_brand_name":"CISPLATIN","generic_name":"Cisplatin","approval_date":"2026-10-29","application_type_full":"New Drug Application","canonical_url":"https://api.morvs.ai/drug-approval/NDA220748"},{"application_number":"ANDA205444","sponsor_name":"ACTAVIS LABS FL INC","application_type":"ANDA","primary_brand_name":"OXCARBAZEPINE","generic_name":"Oxcarbazepine","approval_date":"2026-10-28","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA205444"},{"application_number":"ANDA216722","sponsor_name":"SINOPEP ALLSINO","application_type":"ANDA","primary_brand_name":"FULVESTRANT","generic_name":"Fulvestrant","approval_date":"2026-10-28","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA216722"},{"application_number":"ANDA220782","sponsor_name":"RUBICON RESEARCH","application_type":"ANDA","primary_brand_name":"TRIAMTERENE","generic_name":"Triamterene","approval_date":"2026-10-28","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220782"},{"application_number":"ANDA220602","sponsor_name":"NEURORX","application_type":"ANDA","primary_brand_name":"KETAMINE HYDROCHLORIDE","generic_name":"Ketamine Hydrochloride","approval_date":"2026-10-28","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220602"},{"application_number":"ANDA220379","sponsor_name":"TEVA PHARMACEUTICALS INC","application_type":"ANDA","primary_brand_name":"OLANZAPINE AND SAMIDORPHAN","generic_name":"Olanzapine, Samidorphan","approval_date":"2026-10-28","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220379"},{"application_number":"ANDA214747","sponsor_name":"ALEMBIC","application_type":"ANDA","primary_brand_name":"VENETOCLAX","generic_name":"Venetoclax","approval_date":"2026-10-28","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA214747"},{"application_number":"BLA761187","sponsor_name":"XBRANE BIOPHARMA AB","application_type":"BLA","primary_brand_name":"RANIBIZUMAB","generic_name":"Ranibizumab","approval_date":"2026-10-27","application_type_full":"Biologics License Application","canonical_url":"https://api.morvs.ai/drug-approval/BLA761187"},{"application_number":"ANDA221339","sponsor_name":"MSN LABORATORIES PRIVATE LIMITED","application_type":"ANDA","primary_brand_name":null,"generic_name":null,"approval_date":"2026-10-27","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA221339"},{"application_number":"ANDA221213","sponsor_name":"ZYDUS LIFESCIENCES","application_type":"ANDA","primary_brand_name":"TRANEXAMIC ACID","generic_name":"Tranexamic Acid","approval_date":"2026-10-27","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA221213"},{"application_number":"ANDA212247","sponsor_name":"TEVA PHARMS USA","application_type":"ANDA","primary_brand_name":"RIVAROXABAN","generic_name":"Rivaroxaban","approval_date":"2026-10-27","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA212247"},{"application_number":"ANDA220384","sponsor_name":"SOMERSET THERAPEUTICS, LLC","application_type":"ANDA","primary_brand_name":"TIVOZANIB","generic_name":"Tivozanib","approval_date":"2026-10-26","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220384"},{"application_number":"ANDA220400","sponsor_name":"GLAND","application_type":"ANDA","primary_brand_name":"EPINEPHRINE","generic_name":"Epinephrine","approval_date":"2026-10-26","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220400"},{"application_number":"ANDA216072","sponsor_name":"SENORES PHARMS","application_type":"ANDA","primary_brand_name":"PROPRANOLOL HYDROCHLORIDE","generic_name":"Propranolol Hydrochloride","approval_date":"2026-10-26","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA216072"},{"application_number":"ANDA217267","sponsor_name":"ALEMBIC","application_type":"ANDA","primary_brand_name":"VALGANCICLOVIR HYDROCHLORIDE","generic_name":"Valganciclovir Hydrochloride","approval_date":"2026-10-26","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA217267"},{"application_number":"ANDA221194","sponsor_name":"BIONPHARMA","application_type":"ANDA","primary_brand_name":"TRIMETHOPRIM","generic_name":"Trimethoprim","approval_date":"2026-10-23","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA221194"},{"application_number":"ANDA214412","sponsor_name":"DR REDDYS","application_type":"ANDA","primary_brand_name":"TERIPARATIDE","generic_name":"Teriparatide","approval_date":"2026-10-23","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA214412"},{"application_number":"ANDA205797","sponsor_name":"CADILA PHARMS LTD","application_type":"ANDA","primary_brand_name":"AMLODIPINE BESYLATE AND VALSARTAN","generic_name":"Amlodipine Besylate","approval_date":"2026-10-21","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA205797"},{"application_number":"NDA221276","sponsor_name":"GLAXOSMITHKLINE LLC","application_type":"NDA","primary_brand_name":"HIBSAGO","generic_name":"Bepirovirsen","approval_date":"2026-10-20","application_type_full":"New Drug Application","canonical_url":"https://api.morvs.ai/drug-approval/NDA221276"},{"application_number":"ANDA221301","sponsor_name":"ZYDUS LIFESCIENCES","application_type":"ANDA","primary_brand_name":"BRIVARACETAM","generic_name":"Brivaracetam","approval_date":"2026-10-20","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA221301"},{"application_number":"ANDA220407","sponsor_name":"ZYDUS PHARMS","application_type":"ANDA","primary_brand_name":"ESTRADIOL AND LEVONORGESTREL","generic_name":"Estradiol","approval_date":"2026-10-19","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220407"},{"application_number":"NDA219456","sponsor_name":"FRESENIUS MEDCL CARE","application_type":"NDA","primary_brand_name":"CALREZDY","generic_name":"Calcuim Chloride","approval_date":"2026-10-19","application_type_full":"New Drug Application","canonical_url":"https://api.morvs.ai/drug-approval/NDA219456"},{"application_number":"NDA219455","sponsor_name":"FRESENIUS MEDCL CARE","application_type":"NDA","primary_brand_name":"CIENBY","generic_name":"Sodium Ctirate","approval_date":"2026-10-19","application_type_full":"New Drug Application","canonical_url":"https://api.morvs.ai/drug-approval/NDA219455"},{"application_number":"ANDA218930","sponsor_name":"KINDOS","application_type":"ANDA","primary_brand_name":"ERIBULIN MESYLATE","generic_name":"Eribulin Mesylate","approval_date":"2026-10-19","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA218930"},{"application_number":"ANDA217103","sponsor_name":"TEVA PHARMS INC","application_type":"ANDA","primary_brand_name":"DEFLAZACORT","generic_name":"Deflazacort","approval_date":"2026-10-19","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA217103"},{"application_number":"ANDA220783","sponsor_name":"ZYDUS PHARMS","application_type":"ANDA","primary_brand_name":"ROMIDEPSIN","generic_name":"Romidepsin","approval_date":"2026-10-19","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220783"},{"application_number":"ANDA219794","sponsor_name":"GALENICUM HEALTH SLU","application_type":"ANDA","primary_brand_name":null,"generic_name":null,"approval_date":"2026-10-16","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA219794"},{"application_number":"ANDA220432","sponsor_name":"DR REDDYS","application_type":"ANDA","primary_brand_name":"LORATADINE AND PSEUDOEPHEDRINE SULFATE","generic_name":"Loratadine","approval_date":"2026-10-16","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA220432"},{"application_number":"ANDA219628","sponsor_name":"SENTISS PHARMA","application_type":"ANDA","primary_brand_name":"ATROPINE SULFATE","generic_name":"Atropine Sulfate","approval_date":"2026-10-16","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA219628"},{"application_number":"ANDA219588","sponsor_name":"NOVAST LABS","application_type":"ANDA","primary_brand_name":"PROGESTERONE","generic_name":"Progesterone","approval_date":"2026-10-16","application_type_full":"Abbreviated New Drug Application (Generic)","canonical_url":"https://api.morvs.ai/drug-approval/ANDA219588"},{"application_number":"NDA221033","sponsor_name":"ROSEMONT PHARMS","application_type":"NDA","primary_brand_name":"YULZETY","generic_name":"Rivaroxaban","approval_date":"2026-10-16","application_type_full":"New Drug Application","canonical_url":"https://api.morvs.ai/drug-approval/NDA221033"},{"application_number":"NDA220341","sponsor_name":"ALCON LABORATORIES, INC.","application_type":"NDA","primary_brand_name":"BRYTLY","generic_name":"Brytly (Apraclonidine)","approval_date":"2026-10-16","application_type_full":"New Drug Application","canonical_url":"https://api.morvs.ai/drug-approval/NDA220341"}]}